Medios AG (0QB4.L)
EUR 11.94
(5.29%)
EUR 11.94
(5.29%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 594.75 Million EUR | 3.26% |
| 2022 | 575.95 Million EUR | 9.89% |
| 2021 | 524.14 Million EUR | 169.43% |
| 2020 | 194.53 Million EUR | 66.89% |
| 2019 | 116.56 Million EUR | 18.44% |
| 2018 | 98.41 Million EUR | 59.49% |
| 2017 | 61.7 Million EUR | 28.93% |
| 2016 | 47.86 Million EUR | 9299.04% |
| 2015 | 509.2 Thousand EUR | 467.16% |
| 2014 | 89.78 Thousand EUR | -61.69% |
| 2013 | 234.34 Thousand EUR | -46.87% |
| 2012 | 441.11 Thousand EUR | -32.91% |
| 2011 | 657.47 Thousand EUR | -23.5% |
| 2010 | 859.39 Thousand EUR | -80.74% |
| 2009 | 4.46 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 932.29 Million EUR | 47.79% |
| 2024 Q1 | 630.81 Million EUR | 6.06% |
| 2023 Q2 | 628.19 Million EUR | 1.48% |
| 2023 Q3 | 625.41 Million EUR | -0.44% |
| 2023 FY | 594.75 Million EUR | 3.26% |
| 2023 Q4 | 594.75 Million EUR | -4.9% |
| 2023 Q1 | 619.06 Million EUR | 7.48% |
| 2022 Q4 | 575.95 Million EUR | -2.06% |
| 2022 Q2 | 619.29 Million EUR | 2.04% |
| 2022 FY | 575.95 Million EUR | 9.89% |
| 2022 Q1 | 606.93 Million EUR | 15.8% |
| 2022 Q3 | 588.04 Million EUR | -5.05% |
| 2021 Q1 | 453.9 Million EUR | 133.33% |
| 2021 Q3 | 457.63 Million EUR | 2.04% |
| 2021 Q4 | 524.14 Million EUR | 14.53% |
| 2021 FY | 524.14 Million EUR | 169.43% |
| 2021 Q2 | 448.49 Million EUR | -1.19% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 194.53 Million EUR | 66.89% |
| 2020 Q4 | 194.53 Million EUR | -6.9% |
| 2020 Q3 | 208.94 Million EUR | 3.36% |
| 2020 Q2 | 202.14 Million EUR | 0.0% |
| 2019 Q4 | 116.56 Million EUR | 0.0% |
| 2019 FY | 116.56 Million EUR | 18.44% |
| 2019 Q2 | 111.73 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2018 Q1 | 87.34 Million EUR | 41.55% |
| 2018 FY | 98.41 Million EUR | 59.49% |
| 2018 Q4 | 98.41 Million EUR | 0.0% |
| 2018 Q3 | 98.41 Million EUR | 12.67% |
| 2018 Q2 | 87.34 Million EUR | 0.0% |
| 2017 Q4 | 61.7 Million EUR | 0.0% |
| 2017 Q3 | 61.7 Million EUR | 25.88% |
| 2017 Q2 | 49.02 Million EUR | -0.0% |
| 2017 Q1 | 49.02 Million EUR | 2.43% |
| 2017 FY | 61.7 Million EUR | 28.93% |
| 2016 Q2 | 297.74 Thousand EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 FY | 47.86 Million EUR | 9299.04% |
| 2016 Q4 | 47.86 Million EUR | -0.0% |
| 2016 Q3 | 47.86 Million EUR | 15974.57% |
| 2015 Q4 | 509.2 Thousand EUR | 0.0% |
| 2015 FY | 509.2 Thousand EUR | 467.16% |
| 2015 Q2 | 72.41 Thousand EUR | 0.0% |
| 2014 Q4 | 89.78 Thousand EUR | 0.0% |
| 2014 FY | 89.78 Thousand EUR | -61.69% |
| 2014 Q2 | 246 Thousand EUR | 0.0% |
| 2013 Q2 | 267 Thousand EUR | 0.0% |
| 2013 Q4 | 234.34 Thousand EUR | 0.0% |
| 2013 FY | 234.34 Thousand EUR | -46.87% |
| 2012 Q2 | 565 Thousand EUR | 0.0% |
| 2012 Q4 | 441.11 Thousand EUR | 0.0% |
| 2012 FY | 441.11 Thousand EUR | -32.91% |
| 2011 FY | 657.47 Thousand EUR | -23.5% |
| 2011 Q4 | 657.47 Thousand EUR | 0.0% |
| 2011 Q2 | 713 Thousand EUR | 0.0% |
| 2010 Q4 | 859.39 Thousand EUR | 0.0% |
| 2010 FY | 859.39 Thousand EUR | -80.74% |
| 2010 Q2 | 4.23 Million EUR | 0.0% |
| 2009 Q4 | 4.46 Million EUR | 0.0% |
| 2009 FY | 4.46 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cegedim SA | 924.06 Million EUR | 35.638% |
| Guerbet SA | 1.02 Billion EUR | 41.989% |
| Nexus AG | 411.71 Million EUR | -44.457% |
| Bastide Le Confort Médical SA | 647.06 Million EUR | 8.085% |
| Revenio Group Oyj | 137.4 Million EUR | -332.862% |
| Drägerwerk AG & Co. KGaA | 3.25 Billion EUR | 81.736% |
| Sartorius Aktiengesellschaft | 9.75 Billion EUR | 93.903% |
| LNA Santé SA | 1.5 Billion EUR | 60.538% |
| Siemens Healthineers AG | 46.68 Billion EUR | 98.726% |
| Equasens Société anonyme | 394.04 Million EUR | -50.935% |
| Stratec SE | 479.53 Million EUR | -24.028% |